You have 9 free searches left this month | for more free features.

Allogeneic hematopoietic stem cell transplantation

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Intermittent Claudication, PAD, Atherosclerotic Ischemic Disease Trial in Bangkoknoi (PB-MNC therapy, No PB-MNC therapy)

Recruiting
  • Intermittent Claudication
  • +2 more
  • PB-MNC therapy
  • No PB-MNC therapy
  • Bangkoknoi, Bangkok, Thailand
    Faculty of Medicine, Siriraj Hospital, Mahidol University
Dec 16, 2021

Sickle Cell Disease Trial in Amsterdam (Deferasirox 360 MG)

Recruiting
  • Sickle Cell Disease
  • Deferasirox 360 MG
  • Amsterdam, Meibergdreef 9, Netherlands
    Amsterdan UMC location AMC
May 23, 2022

Giant Cell Arteritis Trial in Nice

Completed
  • Giant Cell Arteritis
    • Nice, Alpes-Maritimes, France
      Hospital of the Archet
    Jul 20, 2022

    End Stage Renal Disease (ESRD) Trial in London (Seacalphyx (sodium thiosulfate pentahydrate injection BP) 25%)

    Enrolling by invitation
    • End Stage Renal Disease (ESRD)
    • Seacalphyx (sodium thiosulfate pentahydrate injection BP) 25%
    • London, Ontario, Canada
      London Health Sciences Centre, University Hospital
    Oct 6, 2021

    Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients

    Completed
    • Cytomegalovirus Infection
    • GVHD
      • Regensburg, Germany
        Universitätsklinikum Regensburg
      Aug 7, 2018

      NSCLC Trial in United States (Nivolumab, Ipilimumab)

      Active, not recruiting
      • Non-small Cell Lung Cancer
      • Chicago, Illinois
      • +11 more
      Aug 31, 2022

      Leukemia, B-Cell Trial in Houston (Autologous TriCAR T-cells and lymphodepletion chemo)

      Not yet recruiting
      • Leukemia, B-Cell
      • Autologous TriCAR T-cells and lymphodepletion chemotherapy
      • Houston, Texas
      • +1 more
      Nov 3, 2021

      Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial in China (pembrolizumab, paclitaxel, docetaxel)

      Completed
      • Esophageal Carcinoma
      • Esophagogastric Junction Carcinoma
      • pembrolizumab
      • +3 more
      • Hefei, Anhui, China
      • +22 more
      Aug 16, 2022

      Kidney Transplant; Complications, Pain, Postoperative Trial in Washington (Intravenous Lidocaine, Transversus abdominis plane

      Recruiting
      • Kidney Transplant; Complications
      • Pain, Postoperative
      • Intravenous Lidocaine
      • +2 more
      • Washington, District of Columbia
        George Washington University Hospital
      Sep 10, 2021

      Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

      Recruiting
      • Chronic Myeloid Leukemia in Myeloid Blast Crisis
      • +3 more
      • based decitabine and olverembatinib(HQP1351)chemotherapy
      • Guanzhou, China
        Department of Hematology, Nanfang Hospital, Southern Medical Uni
      Dec 6, 2022

      Rotator Cuff Injuries Trial in Seongnam-si, Seoul (TPX-115, Placebo)

      Active, not recruiting
      • Rotator Cuff Injuries
      • TPX-115
      • Placebo
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
      • +1 more
      Jul 22, 2021

      Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)

      Recruiting
      • Locally Advanced Malignant Solid Neoplasm
      • Metastatic Malignant Solid Neoplasm
      • Larotrectinib Sulfate
      • Houston, Texas
        M D Anderson Cancer Center
      Apr 18, 2022

      Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma Trial in Chicago (Pembrolizumab, Laboratory

      Active, not recruiting
      • Biphasic Mesothelioma
      • +9 more
      • Pembrolizumab
      • +2 more
      • Chicago, Illinois
        University of Chicago
      Apr 18, 2022

      Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in Hefei, Nanjing, Beijing (LUCAR-20S CAR-T

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • +3 more
      • LUCAR-20S CAR-T cells
      • Beijing, Beijing, China
        Beijing Boren Hospital
      Aug 5, 2021

      Using ctDNA to Detect Minimal Residual Disease After Lung Cancer

      Recruiting
      • Non Small Cell Lung Cancer
        • Toronto, Ontario, Canada
        • +2 more
        Feb 14, 2022

        Head Neck Cancer Trial in Boston (Nivolumab, Ipilimumab, Standard of Care Surgery)

        Active, not recruiting
        • Head and Neck Cancer
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Feb 22, 2022

        HIV Trial in Washington (HST-NEETs)

        Active, not recruiting
        • HIV Infections
        • HST-NEETs
        • Washington, District of Columbia
        • +2 more
        Feb 22, 2022

        BCC, BCC - Basal Cell Carcinoma, Basal Cell Carcinoma Trial in New York (drug, procedure, other)

        Recruiting
        • BCC
        • +5 more
        • Jet injection of ALA
        • +3 more
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Feb 23, 2022

        Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

        Not yet recruiting
        • Recurrent Head and Neck Cancer
        • +5 more
        • Saint Louis, Missouri
          Washington University School of Medicine
        Jul 30, 2023

        Acute Myeloid Leukemia Trial in Columbus (Azacitidine, Biopsy, Enasidenib)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Jun 30, 2022

        Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (Cefepime, Imipenem/cilastatin-relebactam,

        Recruiting
        • Hematopoietic and Lymphoid Cell Neoplasm
        • Malignant Solid Neoplasm
        • Houston, Texas
          M D Anderson Cancer Center
        Jul 21, 2022

        Hematologic Malignancies Trial in Hangzhou (RD13-01 cell infusion)

        Completed
        • Hematologic Malignancies
        • RD13-01 cell infusion
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital,College of Medicine, Zhejiang Univ
        Jan 8, 2022

        Acute Myeloid Leukemia Trial in Columbus (Universal Donor Natural Killer Cells)

        Recruiting
        • Acute Myeloid Leukemia
        • Universal Donor Natural Killer Cells
        • Columbus, Ohio
          Nationwide Children's Hospital
        Aug 11, 2022

        Small Cell Lung Cancer Limited Stage Trial in Germany (Durvalumab, standard of care)

        Recruiting
        • Small Cell Lung Cancer Limited Stage
        • Löwenstein, Baden-Würtemberg, Germany
        • +9 more
        May 18, 2022